View in EDS PDF Full Text

IKK2 controls the inflammatory potential of tissue-resident regulatory T cells in a murine gain of function model.

Saved in:
Bibliographic Details
Title: IKK2 controls the inflammatory potential of tissue-resident regulatory T cells in a murine gain of function model.
Authors: Cardinez C; Centre for Personalised Immunology, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.; Translational Research Unit, The Canberra Hospital, Canberra, ACT, Australia.; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.; Division of Genome Sciences and Cancer, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia., Hao Y; Centre for Personalised Immunology, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.; Translational Research Unit, The Canberra Hospital, Canberra, ACT, Australia.; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Department of Medicine, University of Cambridge, Cambridge, UK., Kwong K; Centre for Personalised Immunology, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.; Translational Research Unit, The Canberra Hospital, Canberra, ACT, Australia.; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Department of Medicine, University of Cambridge, Cambridge, UK., Davies AR; Centre for Personalised Immunology, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.; Translational Research Unit, The Canberra Hospital, Canberra, ACT, Australia.; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia., Downes MB; Centre for Personalised Immunology, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.; Translational Research Unit, The Canberra Hospital, Canberra, ACT, Australia.; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia., Roberts NA; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia., Price JD; Division of Genome Sciences and Cancer, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia., Hernandez RA; Centre for Personalised Immunology, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.; Translational Research Unit, The Canberra Hospital, Canberra, ACT, Australia.; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia., Lovell J; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia., Chand R; Centre for Personalised Immunology, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.; Translational Research Unit, The Canberra Hospital, Canberra, ACT, Australia.; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia., Feng ZP; ANU Bioinformatics Consultancy, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia., Enders A; Centre for Personalised Immunology, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia., Vinuesa CG; Centre for Personalised Immunology, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.; Francis Crick Institute, London, UK., Miraghazadeh B; Centre for Personalised Immunology, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.; Translational Research Unit, The Canberra Hospital, Canberra, ACT, Australia.; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia., Cook MC; Centre for Personalised Immunology, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia. mc2386@cam.ac.uk.; Translational Research Unit, The Canberra Hospital, Canberra, ACT, Australia. mc2386@cam.ac.uk.; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia. mc2386@cam.ac.uk.; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Department of Medicine, University of Cambridge, Cambridge, UK. mc2386@cam.ac.uk.
Source: Nature communications [Nat Commun] 2024 Mar 25; Vol. 15 (1), pp. 2345. Date of Electronic Publication: 2024 Mar 25.
Publication Type: Journal Article
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38528069
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: IKK2 controls the inflammatory potential of tissue-resident regulatory T cells in a murine gain of function model.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Cardinez+C%22">Cardinez C</searchLink>; Centre for Personalised Immunology, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.; Translational Research Unit, The Canberra Hospital, Canberra, ACT, Australia.; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.; Division of Genome Sciences and Cancer, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.<br /><searchLink fieldCode="AU" term="%22Hao+Y%22">Hao Y</searchLink>; Centre for Personalised Immunology, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.; Translational Research Unit, The Canberra Hospital, Canberra, ACT, Australia.; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Department of Medicine, University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Kwong+K%22">Kwong K</searchLink>; Centre for Personalised Immunology, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.; Translational Research Unit, The Canberra Hospital, Canberra, ACT, Australia.; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Department of Medicine, University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Davies+AR%22">Davies AR</searchLink>; Centre for Personalised Immunology, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.; Translational Research Unit, The Canberra Hospital, Canberra, ACT, Australia.; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.<br /><searchLink fieldCode="AU" term="%22Downes+MB%22">Downes MB</searchLink>; Centre for Personalised Immunology, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.; Translational Research Unit, The Canberra Hospital, Canberra, ACT, Australia.; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.<br /><searchLink fieldCode="AU" term="%22Roberts+NA%22">Roberts NA</searchLink>; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.<br /><searchLink fieldCode="AU" term="%22Price+JD%22">Price JD</searchLink>; Division of Genome Sciences and Cancer, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.<br /><searchLink fieldCode="AU" term="%22Hernandez+RA%22">Hernandez RA</searchLink>; Centre for Personalised Immunology, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.; Translational Research Unit, The Canberra Hospital, Canberra, ACT, Australia.; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.<br /><searchLink fieldCode="AU" term="%22Lovell+J%22">Lovell J</searchLink>; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.<br /><searchLink fieldCode="AU" term="%22Chand+R%22">Chand R</searchLink>; Centre for Personalised Immunology, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.; Translational Research Unit, The Canberra Hospital, Canberra, ACT, Australia.; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.<br /><searchLink fieldCode="AU" term="%22Feng+ZP%22">Feng ZP</searchLink>; ANU Bioinformatics Consultancy, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.<br /><searchLink fieldCode="AU" term="%22Enders+A%22">Enders A</searchLink>; Centre for Personalised Immunology, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.<br /><searchLink fieldCode="AU" term="%22Vinuesa+CG%22">Vinuesa CG</searchLink>; Centre for Personalised Immunology, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.; Francis Crick Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Miraghazadeh+B%22">Miraghazadeh B</searchLink>; Centre for Personalised Immunology, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.; Translational Research Unit, The Canberra Hospital, Canberra, ACT, Australia.; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.<br /><searchLink fieldCode="AU" term="%22Cook+MC%22">Cook MC</searchLink>; Centre for Personalised Immunology, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia. mc2386@cam.ac.uk.; Translational Research Unit, The Canberra Hospital, Canberra, ACT, Australia. mc2386@cam.ac.uk.; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia. mc2386@cam.ac.uk.; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Department of Medicine, University of Cambridge, Cambridge, UK. mc2386@cam.ac.uk.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2024 Mar 25; Vol. 15 (1), pp. 2345. <i>Date of Electronic Publication: </i>2024 Mar 25.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38528069
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41467-024-45870-3
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2345
    Titles:
      – TitleFull: IKK2 controls the inflammatory potential of tissue-resident regulatory T cells in a murine gain of function model.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Cardinez C
      – PersonEntity:
          Name:
            NameFull: Hao Y
      – PersonEntity:
          Name:
            NameFull: Kwong K
      – PersonEntity:
          Name:
            NameFull: Davies AR
      – PersonEntity:
          Name:
            NameFull: Downes MB
      – PersonEntity:
          Name:
            NameFull: Roberts NA
      – PersonEntity:
          Name:
            NameFull: Price JD
      – PersonEntity:
          Name:
            NameFull: Hernandez RA
      – PersonEntity:
          Name:
            NameFull: Lovell J
      – PersonEntity:
          Name:
            NameFull: Chand R
      – PersonEntity:
          Name:
            NameFull: Feng ZP
      – PersonEntity:
          Name:
            NameFull: Enders A
      – PersonEntity:
          Name:
            NameFull: Vinuesa CG
      – PersonEntity:
          Name:
            NameFull: Miraghazadeh B
      – PersonEntity:
          Name:
            NameFull: Cook MC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 25
              M: 03
              Text: 2024 Mar 25
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2041-1723
          Numbering:
            – Type: volume
              Value: 15
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Nature communications
              Type: main
ResultId 1